596717219	596717219	CD	B-NP	O
|	|	NN	I-NP	O
AYMC	AYMC	NN	I-NP	O
|	|	NN	I-NP	O
15188609	15188609	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7078260	7078260	CD	B-NP	O
|	|	CC	I-NP	O
3/12/2004	3/12/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Pneumonia	Pneumonia	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2004	11/20/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/6/2004	4/6/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O
EANS	EANS	NNS	I-NP	O
,	,	,	O	O
JUSTIN	JUSTIN	NN	B-NP	O
457-27-86-9	457-27-86-9	CD	I-NP	O
Chi	Chi	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/6/04	10/6/04	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VANHYNING	VANHYNING	NNP	B-NP	O
,	,	,	O	O
GLENN	GLENN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Headache	Headache	NNP	B-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
CITRATE	CITRATE	NNP	I-NP	B-protein
950	950	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	I-protein
600	600	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NNP	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
At	At	IN	B-PP	O
10	10	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
-LRB-	-LRB-	JJ	I-NP	O
bedtime	bedtime	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
WILBY	WILBY	NNP	B-NP	O
,	,	,	O	O
BRYANT	BRYANT	NNP	B-NP	O
BRYON	BRYON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
18292438	18292438	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
WASHMUTH	WASHMUTH	NN	B-NP	O
,	,	,	O	O
SCOTTIE	SCOTTIE	NNP	B-NP	O
CLEO	CLEO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
08829375	08829375	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
NIFEREX-150	NIFEREX-150	NN	B-NP	B-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/15/04	11/15/04	CD	B-NP	O
by	by	IN	B-PP	O
BEILER	BEILER	NNP	B-NP	O
,	,	,	O	O
TOMMY	TOMMY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
09767494	09767494	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	I-protein
INTERACTION	INTERACTION	NNP	I-NP	I-protein
:	:	:	O	I-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	B-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
separate	separate	JJ	B-NP	O
doses	dose	NNS	I-NP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/22/04	2/22/04	CD	B-NP	O
by	by	IN	B-PP	O
UREN	UREN	NNP	B-NP	O
,	,	,	O	O
FERMIN	FERMIN	NNP	B-NP	O
JEWEL	JEWEL	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	B-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
SIMETHICONE	SIMETHICONE	NNP	B-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
VITAMIN	VITAMIN	NNP	I-NP	O
E	E	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
200	200	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/25	11/25	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
VITAMIN	VITAMIN	NN	I-NP	B-protein
B	B	NN	I-NP	I-protein
COMPLEX	COMPLEX	NN	I-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
TRIAMCINOLONE	TRIAMCINOLONE	NN	I-NP	O
ACETONIDE	ACETONIDE	NN	I-NP	O
0.5	0.5	CD	B-NP	O
%	%	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
TRIAMCINOLONE	TRIAMCINOLONE	NN	I-NP	O
A.	A.	NN	I-NP	O
.	.	.	O	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

TOPICAL	TOPICAL	NN	B-NP	O
TP	TP	NN	I-NP	O
QID	QID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
area	area	NN	I-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
axilla	axilla	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
give	give	VB	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
any	any	DT	B-NP	O
iron	iron	NN	I-NP	B-protein
supplements	supplement	NNS	I-NP	I-protein
until	until	IN	B-PP	I-protein
August	August	NNP	B-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/15/04	11/15/04	CD	B-NP	O
by	by	IN	B-PP	O
GANAWAY	GANAWAY	NNP	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NNP	B-NP	O
S.	S.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POLYSACCHARIDE	POLYSACCHARIDE	NNP	B-NP	O
IRON	IRON	NNP	I-NP	O
COMPLEX	COMPLEX	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
separate	separate	JJ	B-NP	O
doses	dose	NNS	I-NP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

MICONAZOLE	MICONAZOLE	NN	B-NP	O
NITRATE	NITRATE	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NNP	I-NP	O
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	O
QUICK	QUICK	NNP	I-NP	O
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	O
1-2	1-2	NN	I-NP	O
TAB	TAB	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
XR	XR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METFORMIN	METFORMIN	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
PROTONIX	PROTONIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Very	Very	NN	I-NP	B-protein
low	low	JJ	I-NP	I-protein
fat	fat	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
20gms/day	20gms/day	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Devon	Devon	NNP	I-NP	O
Filgo	Filgo	NNP	I-NP	O
3/18/04	3/18/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Marvin	Marvin	NNP	I-NP	O
Brendle	Brendle	NNP	I-NP	O
6/7/04	6/7/04	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
HORSE	HORSE	NN	B-NP	O
,	,	,	O	O
tricor	tricor	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Shortness	Shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pneumonia	Pneumonia	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
+	+	SYM	B-NP	O
H	H	NN	I-NP	O
pylori	pylori	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
rx	rx	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
Helicobacter	Helicobacter	NN	I-NP	O
pylori	pylori	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
guiac	guiac	NN	I-NP	O
+	+	SYM	I-NP	O
stools	stool	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleeding	bleed	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
diverticulosis	diverticulosis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
diverticulosis	diverticulosis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
polyposis	polyposis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
colonic	colonic	JJ	I-NP	I-protein
polyp	polyp	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
nephrolithiasis	nephrolithiasis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
kidney	kidney	NN	I-NP	I-protein
stone	stone	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
depression	depression	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
depression	depression	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
obesity	obesity	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
obesity	obesity	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
hypertriglyceridemia	hypertriglyceridemia	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
elevated	elevate	VBN	I-NP	O
triglycerides	triglyceride	NNS	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
OSA	OSA	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
contact	contact	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
R	R	NN	I-NP	O
axilla	axilla	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
contact	contact	NN	I-NP	O
dermatitis	dermatitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Schoel	Schoel	NNP	I-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
endoscopy	endoscopy	NN	I-NP	O
on	on	IN	B-PP	O
1/14	1/14	CD	B-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC/HPI	CC/HPI	NN	B-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
y.o.	y.o.	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypertryglyceridemia	hypertryglyceridemia	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
comes	come	VBZ	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
2-day	2-day	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
increasing	increase	VBG	B-VP	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
1-day	1-day	JJ	B-NP	O
h/o	h/o	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
pleuritic	pleuritic	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

7	7	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
noticed	notice	VBD	B-VP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
nocturia	nocturia	NN	B-NP	O
from	from	IN	B-PP	O
2x	2x	NN	B-NP	O
to	to	TO	B-PP	O
6x	6x	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
became	become	VBD	B-VP	O
uncomfortable	uncomfortable	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
sleeping	sleep	VBG	B-VP	O
,	,	,	O	O
could	could	MD	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
deep	deep	JJ	B-NP	O
breath	breath	NN	I-NP	O
without	without	IN	B-PP	O
RUQ	RUQ	NN	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
fever/chills	fever/chill	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
vomiting	vomiting	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
bowel	bowel	NN	B-NP	O
habits	habit	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

Arrived	Arrive	VBN	B-VP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	B-cell_line
8/22	8/22	CD	I-NP	I-cell_line
,	,	,	O	O
given	give	VBN	B-PP	O
i.v.	i.v.	JJ	B-NP	O
Lasix	Lasix	NNP	I-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Per	Per	NN	B-NP	O
problem	problem	NN	I-NP	O
list	list	NN	I-NP	O
.	.	.	O	O

MEDS	MEDS	NNS	B-NP	O
:	:	:	O	O
Not	Not	RB	B-ADJP	O
compliant	compliant	JJ	I-ADJP	O
.	.	.	O	O

Admission	Admission	NN	B-NP	O
-	-	HYPH	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Tiazac	Tiazac	NN	B-NP	O
240	240	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
Metformin	Metformin	NNP	B-NP	O
XR	XR	NNP	I-NP	O
2000	2000	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
Allergies	Allergy	NNS	I-NP	O
:	:	:	O	O
Horse	Horse	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
unknown	unknown	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
TriCort	TriCort	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
rash	rash	NN	I-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
PE	PE	NNP	I-NP	I-protein
3/26	3/26	CD	I-NP	I-protein
T	T	NN	I-NP	I-protein
97.5	97.5	CD	B-NP	I-protein
HR	HR	NN	I-NP	I-protein
108	108	CD	B-NP	I-protein
BP	BP	NN	I-NP	I-protein
196/112	196/112	CD	B-NP	I-protein
RR	RR	NN	I-NP	I-protein
18	18	CD	B-NP	I-protein
SAT	SAT	NN	I-NP	I-protein
96	96	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
RA	RA	NN	I-NP	I-protein
AOX3	AOX3	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NNP	I-NP	O
,	,	,	O	O
lungs	lung	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
no	no	DT	B-NP	O
M/R/G	M/R/G	NN	I-NP	B-protein
,	,	,	O	O
abdom	abdom	NN	B-NP	O
en	en	NN	I-NP	O
obese	obese	NN	I-NP	O
,	,	,	O	O
distended	distend	VBN	B-VP	O
,	,	,	O	O
w/o	w/o	IN	B-PP	O
peritoneal	peritoneal	JJ	B-NP	O
signs	sign	NNS	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
bs	b	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

PE	PE	NN	B-NP	O
3/1	3/1	CD	I-NP	O
Tm	Tm	NN	I-NP	O
99.8	99.8	CD	B-NP	O
HR	HR	NN	I-NP	O
80-90	80-90	CD	B-NP	O
BP	BP	NN	I-NP	O
140-170/80	140-170/80	CD	B-NP	O
-90	-90	CD	I-NP	O
RR	RR	NN	I-NP	B-protein
18	18	CD	B-NP	I-protein
-	-	HYPH	I-NP	O
22	22	CD	I-NP	O
SAT	SAT	NN	I-NP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
3L	3L	NN	I-NP	O
92-94	92-94	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
AOX3	AOX3	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
,	,	,	O	O
lungs	lung	NNS	B-NP	O
and	and	CC	O	O
heart	heart	NN	B-NP	O
WNL	WNL	NNP	I-NP	O
,	,	,	O	O
abd	abd	VBD	B-VP	O
less	less	JJR	B-NP	O
tender	tender	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
.	.	.	O	O

Ischemia	Ischemia	NNP	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
flat	flat	JJ	B-NP	O
x	x	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
.	.	.	O	O

8/22	8/22	CD	B-NP	O
BNP	BNP	NN	I-NP	O
64	64	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
CHF	CHF	NN	I-NP	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
poorly	poorly	RB	B-VP	O
controlled	control	VBN	I-VP	O
in	in	IN	B-PP	O
setting	set	VBG	B-NP	O
of	of	IN	B-PP	O
missing	miss	VBG	B-VP	O
home	home	NN	B-NP	O
meds	med	NNS	I-NP	O
w/bp	w/bp	VBP	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
170	170	CD	B-NP	O
's	's	POS	B-NP	O
/	/	SYM	O	O
90	90	CD	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

Diltiazem	Diltiazem	NN	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	VBN	B-VP	O
in	in	IN	B-PP	O
favor	favor	NN	B-NP	O
of	of	IN	B-PP	O
Metoprolol	Metoprolol	NN	B-NP	O
and	and	CC	O	O
uptitrated	uptitrate	VBN	B-VP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
.	.	.	O	O

Ruled	Rule	VBN	B-VP	O
out	out	RP	B-PRT	O
PE	PE	NN	B-NP	O
with	with	IN	B-PP	O
D-dimer	D-dimer	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
<	<	SYM	O	I-protein
200	200	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

OSA	OSA	NN	B-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
obesity	obesity	NN	I-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
.	.	.	O	O

Failed	Fail	VBN	B-NP	O
2	2	CD	I-NP	O
CPAP	CPAP	NN	I-NP	O
trials	trial	NNS	I-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
fever	fever	NN	B-NP	O
to	to	TO	B-PP	O
101.5	101.5	CD	B-NP	O
,	,	,	O	O
desat	desat	NN	B-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
,	,	,	O	O
tachypneic	tachypneic	JJ	B-NP	O
,	,	,	I-NP	O
pan-cx	pan-cx	NN	I-NP	O
,	,	,	O	O
CXR	CXR	NNP	B-NP	O
LLL	LLL	NNP	I-NP	O
PNA	PNA	NNP	I-NP	O
,	,	,	O	O
Vanco/Levo/Flagyl	Vanco/Levo/Flagyl	NNP	B-NP	O
begun	begun	NNP	I-NP	O
,	,	,	O	O
Vanco	Vanco	NNP	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	VBD	B-VP	O
since	since	IN	B-PP	O
unlikely	unlikely	JJ	B-NP	O
nosocomial	nosocomial	JJ	I-NP	O
,	,	,	O	O
Levo/Flagyl	Levo/Flagyl	NNP	B-NP	O
changed	change	VBD	B-VP	O
to	to	TO	I-VP	O
p.o.	p.o.	VB	I-VP	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
GI	GI	NN	I-NP	O
.	.	.	O	O

8/22	8/22	CD	B-NP	O
Abd	Abd	NN	I-NP	O
CT	CT	NN	I-NP	O
-	-	HYPH	O	O
fatty	fatty	JJ	B-NP	O
liver	liver	NN	I-NP	O
,	,	,	O	O
pancreas	pancreas	NN	B-NP	O
.	.	.	O	O

ALT/AST	ALT/AST	NN	B-NP	O
:	:	:	O	O
133/98	133/98	CD	B-NP	O
,	,	,	O	O
others	other	NNS	B-NP	O
WNL	WNL	NNP	I-NP	B-cell_type
,	,	,	O	O
trending	trend	VBG	B-VP	O
down	down	RP	B-PRT	O
,	,	,	O	O
near	near	IN	B-PP	O
norma	norma	NN	B-NP	O
.	.	.	O	O

TG	TG	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
2032	2032	CD	I-NP	O
.	.	.	O	O

Serological	Serological	JJ	B-NP	O
liver	liver	NN	I-NP	O
dz	dz	NN	I-NP	O
w/u	w/u	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

Gemfibrozil	Gemfibrozil	NNP	B-NP	O
begun	begun	NNP	I-NP	O
.	.	.	O	O

presumed	presume	VBN	B-NP	O
dx	dx	NN	I-NP	O
NASH	NASH	NNP	I-NP	O
,	,	,	O	O
EGD	EGD	NNP	B-NP	O
-	-	HYPH	I-NP	O
antral	antral	JJ	I-NP	O
erosions	erosion	NNS	I-NP	O
,	,	,	O	O
ASA/NSAIDs	ASA/NSAID	NNS	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	VBD	B-VP	O
for	for	IN	B-PP	O
6	6	CD	B-NP	O
-	-	HYPH	I-NP	O
8	8	CD	I-NP	O
wks	wk	NNS	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
END	END	NN	I-NP	O
:	:	:	O	O
Metformin	Metformin	NN	B-NP	O
,	,	,	O	O
ISS	ISS	VBZ	B-VP	O
9/10	9/10	CD	B-NP	O
15	15	CD	I-NP	O
units	unit	NNS	I-NP	O
NPH	NPH	NN	I-NP	O
added	add	VBN	B-VP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
am	am	NN	I-NP	O
FSBG	FSBG	NN	I-NP	O
120	120	CD	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
RENAL/FEN	RENAL/FEN	NN	I-NP	O
.	.	.	O	O

Good	Good	JJ	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
cx	cx	NN	I-NP	O
likely	likely	RB	B-NP	O
contaminant	contaminant	NN	I-NP	O
,	,	,	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
NEURO/PSY	NEURO/PSY	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
self-d/c	self-d/c	NN	I-NP	O
'd	'd	MD	O	O
Wellbutrin	Wellbutrin	NNP	B-NP	O
Effexor	Effexor	NNP	I-NP	O
7d	7d	NNP	I-NP	O
PTA	PTA	NNP	I-NP	O
.	.	.	O	O

Restart	Restart	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
feel	feel	VBP	B-VP	O
fever	fever	NN	B-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
dizziness	dizziness	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
persistent	persistent	JJ	B-NP	O
nausea/vomiting	nausea/vomiting	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-INTJ	O
go	go	VB	B-NP	O
to	to	TO	B-PP	O
all	all	DT	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
appointments	appointment	NNS	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gregorio	Gregorio	NNP	I-NP	O
Fernald	Fernald	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Endocrinology	Endocrinology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/30	8/30	CD	I-NP	O
2	2	CD	I-NP	O
p.m.	p.m.	NN	I-NP	O
in	in	IN	B-PP	O
Stin	Stin	NNP	B-NP	O
Hi	Hi	NNP	I-NP	O
Wi	Wi	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
372	372	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
526-6077	526-6077	CD	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Antonia	Antonia	NNP	I-NP	O
Swarn	Swarn	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
Primary	Primary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Doctor	Doctor	NNP	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
9/17/04	9/17/04	CD	B-NP	O
at	at	IN	B-PP	O
1	1	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
her	her	PRP$	B-NP	O
office	office	NN	I-NP	O
to	to	TO	B-VP	O
confirm	confirm	VB	I-VP	O
at	at	IN	B-PP	O
-LRB-	-LRB-	NNP	B-NP	O
459	459	CD	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
518-1508	518-1508	CD	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
take	take	VB	I-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Satisfactory	Satisfactory	JJ	B-ADJP	O
TO	TO	TO	B-VP	O
DO/PLAN	DO/PLAN	NN	I-VP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Complete	Complete	JJ	I-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
until	until	IN	B-PP	I-protein
10/8/04	10/8/04	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Endocrine	Endocrine	NN	B-NP	O
and	and	CC	I-NP	O
PCP	PCP	NN	I-NP	O
re	re	VBP	B-VP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
lipid	lipid	NN	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
gastric	gastric	JJ	B-NP	O
erosions	erosion	NNS	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
psychiatrist	psychiatrist	NN	I-NP	O
regarding	regard	VBG	B-VP	O
reinitiation	reinitiation	NN	B-NP	O
of	of	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
DEMARIO	DEMARIO	NNP	B-NP	O
,	,	,	O	O
ROSENDO	ROSENDO	NNP	B-NP	O
EUSEBIO	EUSEBIO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LW38	LW38	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/6/04	10/6/04	CD	I-NP	O
@	@	IN	B-NP	O
10	10	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

